<table id="b7370a97-16cd-4a6f-be13-2c6828e95063" width="583" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption> Table 2: Active-Controlled Trial of Glipizide and Metformin HClTablets in Patients with Inadequate Glycemic Control on Diet and Exercise Alone: Summary of Trial Data at 24 Weeks</caption>
<tbody>
<tr>
<td></td>
<td>
<content stylecode="bold">Glipizide</content>
</td>
<td>
<content stylecode="bold">Metformin</content>
</td>
<td>
<content stylecode="bold">Glipizide</content>
</td>
<td>
<content stylecode="bold">Glipizide and</content>
</td>
</tr>
<tr>
<td></td>
<td>
<content stylecode="bold">5 mg tablets </content>
</td>
<td>
<content stylecode="bold">500 mg tablets</content>
</td>
<td>
<content stylecode="bold">and Metformin HCl</content>
</td>
<td>
<content stylecode="bold">Metformin HCl</content>
</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td>
<content stylecode="bold">2.5 mg/250</content>
</td>
<td>
<content stylecode="bold">2.5 mg/500 mg</content>
</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td>
<content stylecode="bold">mg tablets</content>
</td>
<td>
<content stylecode="bold">tablets</content>
</td>
</tr>
<tr>
<td>
<content stylecode="bold">Mean Final Dose</content>
</td>
<td>16.7 mg</td>
<td>1749 mg</td>
<td>7.9 mg/791 mg</td>
<td>7.4 mg/1477 mg</td>
</tr>
<tr>
<td>
<content stylecode="bold">Hemoglobin A</content>
<content stylecode="bold">
<sub>1c</sub>
</content>
<content stylecode="bold"> (%)</content>
</td>
<td>N=168</td>
<td>N=171</td>
<td>N=166</td>
<td>N=163</td>
</tr>
<tr>
<td>Baseline Mean</td>
<td>9.17</td>
<td>9.15</td>
<td>9.06</td>
<td>9.10</td>
</tr>
<tr>
<td>Final Mean</td>
<td>7.36</td>
<td>7.67</td>
<td>6.93</td>
<td>6.95</td>
</tr>
<tr>
<td>Adjusted Mean Change <br/>from Baseline</td>
<td>-1.77</td>
<td>-1.46</td>
<td>-2.15</td>
<td>-2.14</td>
</tr>
<tr>
<td>Difference from <br/>Glipizide</td>
<td></td>
<td></td>
<td>-0.38<sup>a</sup>
</td>
<td>-0.37<sup>a</sup>
</td>
</tr>
<tr>
<td>Difference from <br/>Metformin</td>
<td></td>
<td></td>
<td>-0.70<sup>a</sup>
</td>
<td>-0.69<sup>a</sup>
</td>
</tr>
<tr>
<td>% Patients with Final <br/>HbA<sub>1c</sub> &lt;7%</td>
<td>43.5%</td>
<td>35.1%</td>
<td>59.6%</td>
<td>57.1%</td>
</tr>
<tr>
<td>
<content stylecode="bold">Fasting Plasma </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Glucose (mg/dL)</content>
</td>
<td>N=169</td>
<td>N=176</td>
<td>N=170</td>
<td>N=169</td>
</tr>
<tr>
<td>Baseline Mean</td>
<td>210.7</td>
<td>207.4</td>
<td>206.8</td>
<td>203.1</td>
</tr>
<tr>
<td>Final Mean</td>
<td>162.1</td>
<td>163.8</td>
<td>152.1</td>
<td>148.7</td>
</tr>
<tr>
<td>Adjusted Mean Change <br/>from Baseline</td>
<td>-46.2</td>
<td>-42.9</td>
<td>-54.2</td>
<td>-56.5</td>
</tr>
<tr>
<td>Difference from <br/>Glipizide</td>
<td></td>
<td></td>
<td>-8.0</td>
<td>-10.4</td>
</tr>
<tr>
<td>Difference from <br/>Metformin</td>
<td></td>
<td></td>
<td>-11.3</td>
<td>-13.6</td>
</tr>
</tbody>
</table>